The immune system usually eradicates HPV in a few years, and the majority of infected individuals do not experience any symptoms.
However, genital or mouth warts, as well as cervix and genital malignancies, are more common in patients with immune system deficiencies.
In 2006, an HPV vaccination was made available to youngsters as young as 11, first for females. In 2020, it was approved for boys. The advantages of the injection have been shown.
To much exceed the dangers, and while certain side effects, such as fever, exhaustion, and headache, have been documented, 96% of these were judged to be non-serious.
At around 60% of teenage girls, the HPV vaccination rate is low when compared to other industrialised nations like the UK, where 85% of adolescent females have received the vaccine.
In contrast to the US, the UK government provides a free universal HPV vaccination program for eighth-grade kids, which is assisting the nation in its efforts to eradicate cervical cancer.
Since HPV has been shown to be responsible for 60 to 70 percent of oropharyngeal cancer occurrences, being vaccinated as a teenager is equally important.
